Stocks · Health care · Biological Products, (No Diagnostic Substances)

Kyverna Therapeutics, Inc.

KYTX Clue Score44
United States Fiscal year ends December CIK 0001994702 Results filed 11 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Karen Marie Walker
15 Dec 2025
Chief Technology Officer
Sold after exercise
23,998
$12.20
$292.78K

What was left out

Form 4 filings counted 17
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 210,877
History held since 12 Feb 2024